These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 17178639)
1. A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Mann JJ; Currier D Arch Suicide Res; 2007; 11(1):3-16. PubMed ID: 17178639 [TBL] [Abstract][Full Text] [Related]
3. Noradrenergic function and HPA axis dysregulation in suicidal behaviour. Jokinen J; Ouda J; Nordström P Psychoneuroendocrinology; 2010 Nov; 35(10):1536-42. PubMed ID: 20576361 [TBL] [Abstract][Full Text] [Related]
4. Recent biologic studies on suicide. Roy A Suicide Life Threat Behav; 1994; 24(1):10-4. PubMed ID: 7515520 [TBL] [Abstract][Full Text] [Related]
5. Hypothalamic-pituitary-adrenal axis function and suicidal behavior in depression. Roy A Biol Psychiatry; 1992 Nov; 32(9):812-6. PubMed ID: 1450295 [TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Mann JJ; Malone KM Biol Psychiatry; 1997 Jan; 41(2):162-71. PubMed ID: 9018386 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid studies in suicide. An overview. Asberg M; Nordström P; Träskman-Bendz L Ann N Y Acad Sci; 1986; 487():243-55. PubMed ID: 2436537 [No Abstract] [Full Text] [Related]
9. Monoamine metabolites in CSF and suicidal behavior. Träskman L; Asberg M; Bertilsson L; Sjöstrand L Arch Gen Psychiatry; 1981 Jun; 38(6):631-6. PubMed ID: 6166274 [TBL] [Abstract][Full Text] [Related]
11. Neuroendocrine challenge studies of suicidal behavior. Weiss D; Coccaro EF Psychiatr Clin North Am; 1997 Sep; 20(3):563-79. PubMed ID: 9323313 [TBL] [Abstract][Full Text] [Related]
12. Reduced CSF concentrations of homovanillic acid and homovanillic acid to 5-hydroxyindoleacetic acid ratios in depressed patients: relationship to suicidal behavior and dexamethasone nonsuppression. Roy A; Agren H; Pickar D; Linnoila M; Doran AR; Cutler NR; Paul SM Am J Psychiatry; 1986 Dec; 143(12):1539-45. PubMed ID: 2431628 [TBL] [Abstract][Full Text] [Related]
13. CSF 5-HIAA and DST non-suppression--orthogonal biologic risk factors for suicide in male mood disorder inpatients. Jokinen J; Nordström AL; Nordström P Psychiatry Res; 2009 Jan; 165(1-2):96-102. PubMed ID: 19062105 [TBL] [Abstract][Full Text] [Related]
15. Self-rated childhood emotional neglect and CSF monoamine indices in abstinent cocaine-abusing adults: possible implications for suicidal behavior. Roy A Psychiatry Res; 2002 Sep; 112(1):69-75. PubMed ID: 12379452 [TBL] [Abstract][Full Text] [Related]
16. CSF metabolites in borderline personality disorder compared with normal controls. Gardner DL; Lucas PB; Cowdry RW Biol Psychiatry; 1990 Aug; 28(3):247-54. PubMed ID: 1696137 [TBL] [Abstract][Full Text] [Related]
17. CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Roy A; Ninan P; Mazonson A; Pickar D; Van Kammen D; Linnoila M; Paul SM Psychol Med; 1985 May; 15(2):335-40. PubMed ID: 2410941 [TBL] [Abstract][Full Text] [Related]
18. Suicide and aggression in schizophrenia. Neurobiologic correlates. Pickar D; Roy A; Breier A; Doran A; Wolkowitz O; Colison J; Agren H Ann N Y Acad Sci; 1986; 487():189-96. PubMed ID: 2436533 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid monoamine metabolites and suicide. Jokinen J; Nordström AL; Nordström P Nord J Psychiatry; 2009; 63(4):276-9. PubMed ID: 19034712 [TBL] [Abstract][Full Text] [Related]
20. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]